Skip to main content

Correlation between high-resolution computed tomography of the chest and pulmonary functions in idiopathic pulmonary fibrosis

Abstract

Background

The idiopathic interstitial pneumonias are a heterogeneous group of non-neoplastic disorders resulting from damage to the lung parenchyma by varying patterns of inflammation and fibrosis. High-resolution computed tomography (HRCT) has become an integral part of the diagnosis and evaluation of the patient with idiopathic interstitial pneumonias.

Aim of the study

The aim of this work was to correlate between HRCT findings and pulmonary functions in patients with idiopathic pulmonary fibrosis (IPF).

Patients and methods

Thirty patients with features consistent with IPF as diagnosed by means of HRCT were included. The severity of IPF was scored using ‘Kasr Al Ainy HRCT scoring of IPF’ in which the lung was divided into six zones, three on each side, with a specific score given for each zone according to the extent of fibrosis. Transthorathic echocardiography was performed for all patients with the estimation of pulmonary artery systolic pressure (PASP).

Results

The mean lower lung zone score according to the HRCT score for severity of IPF was 7.93±2.67, which is consistent with typical basal distribution of IPF. A negative correlation was noted between total HRCT score with forced vital capacity, partial pressure of oxygen, and 6 min walk test. There was a positive correlation between PASP detected using echocardiography and pulmonary artery size measured using HRCT (P=0.022).

Conclusion

There is a positive correlation between PASP detected using echocardiography and pulmonary artery size measured using HRCT. There is a negative correlation between PASP using echo and partial pressure of oxygen in arterial blood gases and also between total lung zone HRCT score and pulmonary functions.

References

  1. [No authors listed]. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults. Introduction. Thorax 1999; 54(Suppl 1):S1–S14.

  2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788–824.

    PubMed  PubMed Central  Article  Google Scholar 

  3. Martinez FJ, Flaherty K. Pulmonary function testing in idiopathic interstitial pneumonias. Proc Am Thorac Soc 2006; 3(4):315–321.

    PubMed  PubMed Central  Article  Google Scholar 

  4. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246(3):697–722.

    PubMed  Article  Google Scholar 

  5. Bradley B, Branley HM, Egan JJ, Greaves MS, Hansell DM, Harrison NK et al. Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax 2008; 63(Suppl 5):1–58.

    Google Scholar 

  6. Remy-Jardin M, Giraud F, Remy J, Wattinne L, Wallaert B, Duhamel A. Pulmonary sarcoidosis: role of CT in the evaluation of disease activity and functional impairment and in prognosis assessment. Radiology 1994; 191 (3):675–680.

    CAS  PubMed  Article  Google Scholar 

  7. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, Saggar R et al. High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007; 132(3):773–779.

    PubMed  Article  Google Scholar 

  8. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG et al. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167(7):962–969.

    PubMed  Article  Google Scholar 

  9. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK et al. Highresolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005; 172(4):488–493.

    PubMed  Article  Google Scholar 

  10. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183(6):788–824.

    PubMed  PubMed Central  Article  Google Scholar 

  11. Rifaat N, Anwar E, Ali YM, Hassan AA. Value of pulmonary rehabilitation in patients with IPF, Egypt J Chest Dis Tuberc 2014; 63:1013–1017.

    Article  Google Scholar 

  12. King TE Jr, Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 2001; 164(7):1171–1181.

    PubMed  Article  Google Scholar 

  13. Watters LC, King TE, Schwarz MI, Waldron JA, Stanford RE, Cherniack RM. A clinical, radiographic, and physiologic scoring system for the longitudinal assessment of patients with idiopathic pulmonary fibrosis. Am Rev Respir Dis 1986; 133(1):97–103.

    CAS  PubMed  Article  Google Scholar 

  14. Collard HR, King TE Jr, Bartelson BB, Vourlekis JS, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168:538–542.

    Article  PubMed  Google Scholar 

  15. Du Bois RM, Weycker D, Albera C, Bradford WZ, Costabel U, Kartashov A et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am J Respir Crit Care Med 2011; 183(9):1231–1237.

    PubMed  Article  Google Scholar 

  16. Swigris JJ, Swick J, Wamboldt FS, Sprunger D, du Bois R, Fischer A et al. Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis. Chest 2009; 136(3):841–848.

    PubMed  PubMed Central  Article  Google Scholar 

  17. Hallstrand TS, Boitano LJ, Johnson WC, Spada CA, Hayes JG, Raghu G. The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur Respir J 2005; 25(1):96–103.

    CAS  PubMed  Article  Google Scholar 

  18. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J 1999; 14(2):270–274.

    CAS  PubMed  Article  Google Scholar 

  19. O’Donnell D. Physiology of interstitial lung disease. In Schwarz M, King T Jr, eds. Interstitial lung disease. Hamilton, ON: Marcel Dekker; 1998: 51–70.

    Google Scholar 

  20. [No authors listed]. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161(Pt 1):646–664.

    Google Scholar 

  21. Caminati A, Bianchi A, Cassandro R, Mirenda MR, Harari S. Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir Med 2009; 103(1):117–123.

    PubMed  Article  Google Scholar 

  22. Doherty MJ, Pearson MG, O’Grady EA, Pellegrini V, Calverley PM. Cryptogenic fibrosing alveolitis with preserved lung volumes. Thorax 1997; 52(11):998–1002.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. Enomoto N, Suda T, Kato M, Kaida Y, Nakamura Y, Imokawa S et al. Quantitative analysis of fibroblastic foci in usual interstitial pneumonia. Chest 2006; 130(1):22–29.

    PubMed  Article  Google Scholar 

  24. Jegal Y, Kim DS, Shim TS, Lim CM, Do Lee S, Koh Y et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005; 171(6):639–644.

    PubMed  Article  Google Scholar 

  25. Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30:2493–2537.

    PubMed  Article  Google Scholar 

  26. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129(3):746–752.

    PubMed  Article  Google Scholar 

  27. Corte TJ, Wort SJ, Gatzoulis MA, Macdonald P, Hansell DM, Wells AU. Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension. Thorax 2009; 64(10):883–888.

    CAS  PubMed  Article  Google Scholar 

  28. Ng CS, Wells AU, Padley SP. A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter. J Thorac Imaging 1999; 14(4):270–278.

    CAS  Article  PubMed  Google Scholar 

  29. Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology 2010; 254(2):609–616.

    PubMed  Article  Google Scholar 

  30. Grosse C, Grosse A. CT findings in diseases associated with pulmonary hypertension: a current review. Radiographics 2010; 30(7):1753–1777.

    PubMed  Article  Google Scholar 

  31. Peña E, Dennie C, Veinot J, Muñiz SH. Pulmonary hypertension: how the radiologist can help. Radiographics 2012; 32(1):9–32.

    PubMed  Article  Google Scholar 

  32. Todd NW, Lavania S, Park MH, Iacono AT, Franks TJ, Galvin JR et al. Variable prevalence of pulmonary hypertension in patients with advanced interstitial pneumonia. J Heart Lung Transplant 2010; 29(2):188–194.

    PubMed  PubMed Central  Article  Google Scholar 

  33. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, Decker PA, Ryu JH. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest 2005; 128(Suppl):616S–617S.

    Article  PubMed  Google Scholar 

  34. Zisman DA, Ross DJ, Belperio JA, Saggar R, Lynch JP 3rd, Ardehali A, Karlamangla AS. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2007; 101(10):2153–2159.

    PubMed  PubMed Central  Article  Google Scholar 

  35. Wells AU, Rubens MB, du Bois RM, Hansell DM. Serial CT in fibrosing alveolits: prognostic significance of the initial pattern. Am J Respir Crit Care Med 1993; 161:1159–1165.

    CAS  Google Scholar 

  36. Staples CA, Müller NL, Vedal S, Abboud R, Ostrow D, Miller RR. Usual interstitial pneumonia: correlation of CT with clinical, functional, and radiologic findings. Radiology 1987; 162(2):377–381.

    CAS  PubMed  Article  Google Scholar 

  37. Xaubet A, Agustí C, Luburich P, Roca J, Montón C, Ayuso MC et al. Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158(2):431–436.

    CAS  Article  PubMed  Google Scholar 

  38. Wells AU, King AD, Rubens MB, Cramer D, du Bois RM, Hansell DM. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography. Am J Respir Crit Care Med 1997; 155(4):1367–1375.

    CAS  PubMed  Article  Google Scholar 

  39. Mogulkoc N, Brutsche MH, Bishop PW, Greaves SM, Horrocks AW, Egan JJ. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001; 164(1):103–108.

    CAS  PubMed  Article  Google Scholar 

  40. Shin KM, Lee KS, Chung MP, Han J, Bae YA, Kim TS, Chung MJ. Prognostic determinants among clinical, thin-section CT, and histopathologic findings for fibrotic idiopathic interstitial pneumonias: tertiary hospital study. Radiology 2008; 249(1):328–337.

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ahmed M. Abd El-Hafeez.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Abou Youssuf, H.A., Sabry, Y.Y., Abd El-Hafeez, A.M. et al. Correlation between high-resolution computed tomography of the chest and pulmonary functions in idiopathic pulmonary fibrosis. Egypt J Bronchol 10, 330–336 (2016). https://doi.org/10.4103/1687-8426.193633

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.193633

Keywords

  • high-resolution computed tomography
  • idiopathic pulmonary fibrosis
  • pulmonary function tests